We evaluated serum gastrin responses to a test meal in normal subjects and diabetic patients with or without vagal neuropathy. Vagal neuropathy was defined as a heart rate variation during deep breathing of < 9 beats/min. Forty-three percent (54 out of 124) of the diabetic patients had abnormal heart rate variation, compared with 5% (3 out of 53) of the normal subjects. Serum gastrin responses to a test meal were examined in 17 normal subjects, 20 out of 70 diabetic patients without vagal neuropathy and 17 out of 54 diabetic patients with vagal neuropathy. Meal-stimulated gastrin levels were significantly higher in the diabetic patients with vagal neuropathy than in the normal subjects, while the findings in the diabetic patients without vagal neuropathy were similar to those in normal subjects, These data suggest that augmented gastrin responses are due to vagal denervation induced by autonomic neuropathy.
Patients and methods
We measured heart rate variation in 53 non-diabetic subjects and in 124 diabetic patients diagnosed by the diagnostic criteria of the National Institutes of Health [5] . Clinical details are shown in Table 1 . The subjects were connected to an electrocardiometer, rested supine for a few minutes and then heart rate variation was recorded during deep breathing at a regular rate of 6 deep breaths/min (5 s in, 5 s out) for 1 rain [3] . Heart rate variation on deep breathing was assessed by measuring the difference between maximum and minimum heart rates (in beats/min). The diabetic patients were divided into two groups depending on the presence of vagal neuropathy. Vagal neuropathy was defined as heart rate variation during deep breathing of < 9 beats/min. Serum gastrin responses to a test meal were measured in 17 out of the 53 control subjects, 20 out of the 70 diabetic patients without vagal neuropathy and 17 out of the 54 diabetic patients with vagal neuropathy. Among the 17 control subjects, the 20 patients without vagal neuropathy and the 17 patients with vagal neuropathy, there were no differences in age or percentage of ideal body weight ( Table 1 ). The average duration of the disease in patients with vagal neuropathy was longer than in patients without, but there were no statistically significant differences between the two groups. Increased heart rates were seen in the diabetic patients with vagal neuropathy and heart rate variation during deep breathing was greatly diminished. Three out of the 17 diabetic patients with vagal neuropathy had gastro-intestinal symptoms of nausea, recurrent vomiting and diarrhoea. The others in this group and all diabetic patients without vagal neuropathy had no gastro-intestinal symptoms. No subject undergoing the test had renal insufficiency. Blood samples were obtained before (basal), 30 and 60 min after oral administration of a canned fluid diet (Okunos-A, Okunos, Hirakawacho, Tokyo). This consists of 9.8 g protein, 28.6 g carbohydrate and 5.2 g fat. The volume was 200 ml and the pH approximately 6.3. Sera were stored at -20 ~ until assayed. Serum gastrin levels were measured by radioimmunoassay, using a gastrin radioimmunoassay kit (CIS; Commissariat fl l'Energie Atomique, Gif-sur-Yvette, France) [6] . The antiserum used in the assay allows correct recognition of human big gastrin. Cross-reactivity with pentagastrin was < 10 -3, and with the octapeptide of cholecystokinin and secretin was < 10-Q In 17 out of the 20 diabetic patients without vagal neuropathy and 14 out of the 17 diabetic patients with vagal neuropathy, gastric parietal cell antibody was evaluated by an indirect immunofluorescence technique [7] , using Wistar rat stomach.
For statistical analysis, Student's t-test and the Mann-Whitney U test were used as appropriate. Responses of heart rate variation on deep breathing in 53 nondiabetic subjects and in 124 diabetic patients. The vertical dotted line indicates the lower limits of normal which were determined by Mackay et al. [3] . The heart rate variations in the diabetic patients were significantly different from those in the non-diabetic subjects (p < o.ol)
Results Figure 1 shows heart rate variation on deep breathing in the non-diabetic and diabetic subjects. Forty-three percent of diabetic patients (54 out of 124) had abnormal heart rate variation scores compared with only 5% of non-diabetic subjects (3 out of 53). Using the MannWhitney U test, the results of heart rate variation were significantly different from the findings in the non-diabetic subjects (p < 0.01). Basal gastrin levels in normal subjects averaged 48.0+4.4pg/ml and serum gastrin increased significantly to 83.8 _+ 9.3 pg/ml 30min after a test meal (Fig. 2) . Similarly, in diabetic patients with or without vagal neuropathy, serum gastrin was stimulated significantly by a test meal. Basal and meal-stimulated gastrin levels were significantly higher in diabetic patients with vagal neuropathy than in normal subjects and diabetic patients without vagal neuropathy, while levels in diabetic patients without vagal neuropathy were similar to those in normal subjects. Using the Mann-Whitney U test (Fig. 3) , basal gastrin levels and gastrin responsiveness to the test meal were significantly greater in diabetic patients with vagal neuropathy than in normal subjects and diabetic patients without vagal neuropathy (p < 0.01). Gastric parietal cell antibody was present in one of the 17 patients without vagal neuropathy and in two of the 14 patients with vagal neuropathy. Enhanced gastrin responses were observed only in one of the three patients and this patient also had abnormal heart rate variation.
Discussion
Augmented serum gastrin responses to test meals were evident in about half our diabetic patients with vagal neuropathy diagnosed by heart rate variation during deep breathing. As the control subjects showed a significant response in serum gastrin levels to the test meal, this test is a valuable way of assessing gastrin responsiveness. Among various foods tested, protein was the most potent stimulant of gastrin release [8, 9] . Gastrin responses in diabetic patients without vagal neuropathy were similar to those in the non-diabetic subjects.
Mackay et al. [3] reported that detecting autonomic neuropathy in diabetic patients by the heart rate responses to deep breathing provided a quantitative assessment of the degree of autonomic damage and that this is the simplest test of autonomic function, suggesting that loss of heart rate variation is due most probably to vagal neuropathy. at 60 min Gastrin (pg/ml) Fig. 3A -C. Basal gastrin levels and gastrin levels at 60 min in A normal subjects, B diabetic patients without vagal neuropathy and C diabetic patients with vagal neuropathy. Using the Mann-Whitney U test, in diabetic patients with vagal neuropathy basal gastrin levels and gastrin levels at 60 rain were significantly different from normal subjects and diabetic patients without vagal neuropathy (basal gastrin levels: p <0.01, gastrin levels at 60 rain: p <0.01)
The findings of enhanced gastrin responses to a test meal in the diabetic patients with vagal neuropathy supports the thesis that hyper-responsiveness of gastrin to a test meal in diabetic patients may be due to vagal denervation. However, we cannot exclude the possibility that it might be due to differences in acid secretion, because gastric acid was not examined in this study. Feldman et al. [4] observed hypergastrinaemia in long-standing insulin-dependent diabetic patients who secreted less gastric acid than non-diabetic subjects, suggesting that diabetic patients had a hypergastrinaemic response to food, presumably because of vagal neuropathy. On the other hand, hypergastrinaemia was reportedly higher in duodenal ulcer patients after vagotomy [10, 11] . Serum gastrin levels were also increased in dogs after vagotomy [12, 131. These observations support our thesis that in diabetic patients with vagal neuropathy, enhanced gastrin responses to a test meal may be mostly due to vagal denervation per se. Enhanced gastrin responses to a test meal were observed only in about half the diabetic patients with vagal neuropathy and in the other patients, the same degree of response as seen in normal subjects and diabetic patients without vagal neuropathy. In patients with peptic ulcer, hypergastrinaemia is often detected not only after truncal vagotomy but also after selective proximal vagotomy [14] [15] [16] . The vagal inhibitory pathway for gastrin release may be located in the proximal stomach [14] . Thus, the vagus in a portion of the stomach may be denervated in some diabetic patients with vagal neuropathy, and hyper-responsiveness of gastrin would ensue.
As the test meal in our studies had a pH 6.3, intragastric acid concentration might not be relevant. It is possible that achlorhydria secondary to vagal neuropathy caused an increased gastrin response, as seen in patients with pernicious anaemia. However, Feldman et al., who controlled gastric pH by titration in vivo, found that gastrin responses to food were greater after vagotomy compared with before vagotomy in patients with duodenal ulcer [141. Enhanced gastrin responses in diabetic patients with vagal neuropathy are therefore unlikely to be simply due to reduction in gastric acidity.
Gastric parietal cell antibody was observed in three of the 31 patients examined and only one had increased gastrin responses to a test meal and this patient also had vagal neuropathy. It is, therefore, unlikely that increased gastrin responses in diabetic patients with vagal neuropathy were induced by achlorhydria due to atrophic gastritis. Renal failure is reportedly one cause of hypergastrinaemia in diabetic patients [17] but patients with renal insufficiency were excluded from our study.
Finally, many patients with gastroparesis diabeticorum are free of gastrointestinal symptoms, although some develop a syndrome characterized by nausea and recurrent vomiting [1] . In this study, only three patients with both vagal neuropathy and enhanced gastrin responses complained of these symptoms and five patients with both signs did not complain of gastrointestinal symptoms. Thus, augmented gastrin responses in diabetic patients with vagal neuropathy may be the early manifestation of gastroparesis diabeticorum.
